GO
Loading...

Johnson & Johnson

More

  • Ebola vaccine from Glaxo passes early safety test Thursday, 27 Nov 2014 | 1:56 AM ET

    An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects, scientists reported on Wednesday.

  • Dow, S&P close at records; Intel up 4% Thursday, 20 Nov 2014 | 4:00 PM ET
    Traders on the floor of the New York Stock Exchange.

    U.S. stocks closed at highs after encouraging domestic data alleviated concerns over continued signs of slowing growth in Europe and China.

  • NEW YORK, Nov 20- Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs' lawyer said, in the third courtroom loss for the company over the products. Jurors also said Boston Scientific had acted with "gross negligence" and awarded each woman $1 million in punitive damages, Monsour said.

  • Bonds shrug off better data, as Alibaba debuts Thursday, 20 Nov 2014 | 2:11 PM ET
    Traders on the floor of the New York Stock Exchange.

    Despite strong economic data on housing sales and from the Philadelphia Fed, the bond market remained largely nonchalant. Blame Alibaba.

  • NEW YORK, Nov 20- Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs' lawyer said, in the third courtroom loss for the company over the products. Jurors also said Boston Scientific had acted with "gross negligence" and awarded each woman $1 million in punitive damages, Monsour said.

  • BUSINESS-NEWS-SCHEDULE AT 1630 GMT /11:30 AM ET Wednesday, 19 Nov 2014 | 11:40 AM ET

    WASHINGTON- President Barack Obama might be open to using the Keystone pipeline as leverage with Republicans if they cooperate on other aspects of his long-stalled domestic agenda, such as investing in infrastructure, closing tax loopholes or reducing carbon emissions. U.S. regulator seeks nationwide recall of Takata air bags. WASHINGTON- The U.S. auto...

  • BUSINESS-NEWS-SCHEDULE AT 1600 GMT /11:00 AM ET Wednesday, 19 Nov 2014 | 11:07 AM ET

    WASHINGTON- President Barack Obama might be open to using the Keystone pipeline as leverage with Republicans if they cooperate on other aspects of his long-stalled domestic agenda, such as investing in infrastructure, closing tax loopholes or reducing carbon emissions. WASHINGTON- The U.S. auto safety regulator has told Japanese supplier Takata Corp and...

  • Early Movers: LOW, SPLS, PETM, DRI, DG & more Wednesday, 19 Nov 2014 | 8:12 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • NEW YORK, Nov 19- Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson& Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday. A federal court judge in New York will hear the case without a jury and decide whether Guidant, through its successor Boston Scientific, should be...

  • Stocks end little moved; benchmarks up for 4th week Friday, 14 Nov 2014 | 4:14 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks stepped slightly higher Friday, with investors tracking the price of oil.

  • *Baker Hughes confirms merger talks with Halliburton. *Geron jumps on licensing deal with Johnson& Johnson. NEW YORK, Nov 14- U.S. stocks opened flat on Friday, with the S&P on track for a fourth straight weekly advance, after data on retail sales and ahead of a report on consumer sentiment.

  • *Baker Hughes confirms merger talks with Halliburton. *Geron jumps on licensing deal with Johnson& Johnson. NEW YORK, Nov 14- U.S. stock index were set to open little changed on Friday, with the S&P on track for a fourth straight weekly advance, after data on retail sales and ahead of a report on consumer sentiment.

  • *Baker Hughes confirms merger talks with Halliburton. *Geron jumps on licensing deal with Johnson& Johnson. *The Thomson Reuters/ University of Michigan preliminary November reading on consumer sentiment is expected later in the session at 9:55 a.m. Expectations call for a reading of 87.5 versus the final October reading of 86.9.

  • Early Movers: BHI, HTZ, SBUX, HLF & more Friday, 14 Nov 2014 | 8:05 AM ET

    Some of the names on the move ahead of the open.

  • Geron sells last drug in pipeline to J&J unit Thursday, 13 Nov 2014 | 6:27 PM ET

    Nov 13- Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson& Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading. The license deal comes as a welcome break to the company, which has seen its stock price drop from a high of $71.69 in 2000 to $2.31 on Thursday. If successful, imetelstat would...

  • Nov 13- Puma Biotechnology Inc said its cancer drug failed as a primary treatment for breast cancer patients in a mid-stage study, sending its shares down 14 percent in extended trading. Puma Biotech's founder and Chief Executive Alan Auerbach had also founded cancer drug developer Cougar Biotech which was sold to Johnson& Johnson for about 1 billion in 2009..

  • WASHINGTON, Nov 12- Republicans in the U.S. Congress will soon move to kill a medical device tax imposed less than two years ago under President Barack Obama's healthcare law, congressional aides and analysts said on Wednesday. Though no full-scale repeal of Obamacare is expected, even with the Senate now under Republican control, the move against the tax is part...

  • Republican knives out for Obama's medical devices tax Wednesday, 12 Nov 2014 | 5:25 PM ET

    Last week's elections will elevate Republican Senator Orrin Hatch, a long-standing opponent of the tax, to the chairmanship of the tax-writing finance committee in the Senate. Though no full-scale repeal of Obamacare is expected, even with the Senate under Republican control, the move against the device tax is part of efforts to chip away at the law.

  • One sector growing at double-digit pace in China Monday, 10 Nov 2014 | 11:24 PM ET
    Surgical Team Working In Operating Theatre Wearing Protective Clothing

    China's healthcare sector is growing at more than double the pace of the overall economy, according to the CEO of Johnson & Johnson.

  • Nov 10- Dendreon Corp filed for Chapter 11 bankruptcy protection after sales of the world's first cancer vaccine fell short of expectations and left the company deep in debt. Seattle- based Dendreon said it had agreed terms of a financial restructuring with certain bond holders that may involve a standalone recapitalization or the sale of the company or its...